Michael Okirwoth

634 total citations
6 papers, 96 citations indexed

About

Michael Okirwoth is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Michael Okirwoth has authored 6 papers receiving a total of 96 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Infectious Diseases and 2 papers in Surgery. Recurrent topics in Michael Okirwoth's work include Fungal Infections and Studies (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Antifungal resistance and susceptibility (3 papers). Michael Okirwoth is often cited by papers focused on Fungal Infections and Studies (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Antifungal resistance and susceptibility (3 papers). Michael Okirwoth collaborates with scholars based in Uganda, United States and United Kingdom. Michael Okirwoth's co-authors include David B. Meya, David R. Boulware, Emily Martyn, Lillian Tugume, Ananta Bangdiwala, Morris K Rutakingirwa, Kiiza Kandole Tadeo, Joshua Rhein, John Kasibante and Fiona V Cresswell and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and International Journal of Infectious Diseases.

In The Last Decade

Michael Okirwoth

6 papers receiving 96 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Okirwoth Uganda	5	65	57	42	27	5	6	96
Carola Horn Germany	6	24 0.4×	23 0.4×	32 0.8×	39 1.4×	6 1.2×	11	78
K. Boggian Switzerland	4	70 1.1×	82 1.4×	48 1.1×	4 0.1×	3 0.6×	7	122
Lucia Pareja-Cebrian United Kingdom	4	13 0.2×	28 0.5×	36 0.9×	15 0.6×	2 0.4×	6	71
Mark Fajans Kenya	3	41 0.6×	34 0.6×	13 0.3×	13 0.5×		3	59
Marc-Olivier Vareil France	5	30 0.5×	33 0.6×	29 0.7×	6 0.2×	2 0.4×	10	79
Getachew Seid Ethiopia	10	136 2.1×	101 1.8×	86 2.0×	13 0.5×	1 0.2×	22	170
M. A. von Wichmann Spain	6	27 0.4×	71 1.2×	10 0.2×	16 0.6×	4 0.8×	10	103
Ejaz Ahmed Khan Pakistan	5	40 0.6×	34 0.6×	13 0.3×	4 0.1×	3 0.6×	7	70
A Dorothee Heemskerk United Kingdom	3	63 1.0×	43 0.8×	97 2.3×	39 1.4×	1 0.2×	3	108
Nomonde R. Mvelase South Africa	6	53 0.8×	65 1.1×	29 0.7×	4 0.1×		8	73

Countries citing papers authored by Michael Okirwoth

Since Specialization

Citations

This map shows the geographic impact of Michael Okirwoth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Okirwoth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Okirwoth more than expected).

Fields of papers citing papers by Michael Okirwoth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Okirwoth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Okirwoth. The network helps show where Michael Okirwoth may publish in the future.

Co-authorship network of co-authors of Michael Okirwoth

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Okirwoth. A scholar is included among the top collaborators of Michael Okirwoth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Okirwoth. Michael Okirwoth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

Kagimu, Enock, Nathan C. Bahr, Michael Okirwoth, et al.. (2024). Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Prospective Cohort Study. Clinical Infectious Diseases. 80(2). 417–424. 1 indexed citations

Skipper, Caleb P, Katherine Huppler Hullsiek, Fiona V Cresswell, et al.. (2022). Cytomegalovirus viremia as a risk factor for mortality in HIV-associated cryptococcal and tuberculous meningitis. International Journal of Infectious Diseases. 122. 785–792. 10 indexed citations

Cresswell, Fiona V, David B. Meya, Enock Kagimu, et al.. (2021). High-Dose Oral and Intravenous Rifampicin for the Treatment of Tuberculous Meningitis in Predominantly Human Immunodeficiency Virus (HIV)-Positive Ugandan Adults: A Phase II Open-Label Randomized Controlled Trial. Clinical Infectious Diseases. 73(5). 876–884. 45 indexed citations

Tadeo, Kiiza Kandole, Richard Kwizera, Emily Martyn, et al.. (2021). Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal Meningitis. Journal of Clinical Microbiology. 59(8). e0086021–e0086021. 15 indexed citations

Abassi, Mahsa, Ananta Bangdiwala, Edwin Nuwagira, et al.. (2020). Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis. Clinical Infectious Diseases. 73(9). e3077–e3082. 16 indexed citations

Martyn, Emily, Ananta Bangdiwala, Enock Kagimu, et al.. (2020). Cerebrospinal Fluid Bacillary Load by Xpert MTB/RIF Ultra Polymerase Chain Reaction Cycle Threshold Value Predicts 2-Week Mortality in Human Immunodeficiency Virus–Associated Tuberculous Meningitis. Clinical Infectious Diseases. 73(9). e3505–e3510. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact